PharmaDeals: PharmaDeals Review: Table of Contents

<< Previous Issue

Oct 2005 (Vol:2005, Issue: 64)

Next Issue >>

Download pdf of entire issue

Section: Business Commentaries
Where Does Innovation Prosper? Published: 1 Oct-2005
By: Fintan Walton
Abstract Fulltext:
Section: Deal Trackers
Increlex (mecasermin) Published: 5 Oct-2005
By: Business Review Editor
Abstract Fulltext:
Section: Features
GSK Keeps an Eye on Vaccines Business with Potential ID Biomedical Acquisition Published: 1 Oct-2005
By: Business Review Editor
Abstract Fulltext:
EpiCept Merges with Maxim to Go Public Published: 1 Oct-2005
By: Business Review Editor
Abstract Fulltext:
When and How to Find the Right Partner Published: 1 Oct-2005
By: Business Review Editor
Abstract Fulltext:
Therapy Focus: Schizophrenia Published: 1 Oct-2005
By: Business Review Editor
Abstract Fulltext:
Section: General
Novartis Backs Alnylam and RNAi Published: 5 Oct-2005
By: Business Review Editor
Abstract Fulltext:
ALK-Abello AS Published: 5 Oct-2005
By: Business Review Editor
Abstract Fulltext:
Section: Licensing
Vical Grants More Options to Merck & Co. for Cancer Targets Published: 5 Oct-2005
By: Business Review Editor
Abstract Fulltext:
NexMed Signs Global Licensing Deal with Novartis Published: 5 Oct-2005
By: Business Review Editor
Abstract Fulltext:
Section: Mergers & Acquisitions
Inyx Increases Capabilities in the Inhaled Drug Market Published: 5 Oct-2005
By: Business Review Editor
Abstract Fulltext:
Covance Acquires Clinical Services Facility from West Pharmaceutical Published: 5 Oct-2005
By: Business Review Editor
Abstract Fulltext:
Section: Research & Development
Cyto Pulse Collaborates with US Army Published: 5 Oct-2005
By: Business Review Editor
Abstract Fulltext:
Astex Continues to Sign with Big Pharma Published: 5 Oct-2005
By: Business Review Editor
Abstract Fulltext:

Bookmarks

Bookmark PharmaDeals through one of these social networks.

Table of Contents

Login

Bookmarks